2C5O

DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN

Structural Biology Knowledgebase: 2C5O SBKB.org


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.1 Å
  • R-Value Free: 0.256
  • R-Value Work: 0.195

wwPDB Validation Full Report


Literature

Macromolecules
Sequence Display for 2C5O

Classification: TRANSFERASE

Total Structure Weight: 128101.63

Macromolecule Entities
Molecule Chains Length Organism Details
CELL DIVISION PROTEIN KINASE 2 A, C 298 Homo sapiens EC#: 2.7.11.22 IUBMB
Details: TRIAZOL-1-METHYL-PYRIMIDIN INHIBITOR
Gene Name(s): CDK2 Gene View CDKN2
CYCLIN A2 B, D 260 Homo sapiens Gene Name(s): CCNA2 Gene View CCN1 CCNA

Small Molecules
Ligands 1 Unique
ID Chains Name / Formula / InChI Key 2D Diagram 3D Interactions
CK2
Query on CK2

A, C 4-(2,4-DIMETHYL-1,3-THIAZOL-5-YL)PYRIMIDIN- 2-AMINE
4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2- YLAMINE (Synonym)
C9 H10 N4 S
CTFDMGIBHFQWKB-UHFFFAOYSA-N
Ligand Explorer
 
Binding Pocket (JSmol)
 
Electron Density (JSmol)
External Ligand Annotations
ID Binding Affinity (Sequence Identity %)
CK2 IC50: 6500 nM (100) BindingDB

IC50: 6500 nM  BindingMOAD
IC50: 6500 nM  PDBbind

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.1 Å
  • R-Value Free: 0.256
  • R-Value Work: 0.195
  • Space Group: P 21 21 21
  • Electron Density Server: EDS EDS

Unit Cell:

Length (Å) Angle (°)
a = 74.48 α = 90.00
b = 113.51 β = 90.00
c = 157.08 γ = 90.00

Structure Validation

View Full Validation Report or Ramachandran Plots



Entry History

Deposition Data

  • Deposited Date: 2005-10-30
  • Released Date: 2006-03-01
  • Deposition author(s): Kontopidis, G., Mcinnes, C., Pandalaneni, S.R., Mcnae, I., Gibson, D., Mezna, M., Thomas, M., Wood, G., Wang, S., Walkinshaw, M.D., Fischer, P.M.

Revision History

  • 2011-07-13
    Type: Version format compliance | Details: compliance with PDB Exchange Dictionary V4